BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6168368)

  • 1. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
    van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
    Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple biochemical markers in patients with gynecologic malignancies.
    Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
    Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of tumor markers in clinical oncology].
    Gericke D; Drahovsky D
    Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
    Obata N; Kodama S; Hando T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase specific proteins in human malignant neoplasms.
    Klavins JV
    Ann Clin Lab Sci; 1978; 8(5):366-71. PubMed ID: 81650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and management of cancer using tumor markers].
    Torigoe T; Kato H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)].
    Sekiya S; Kawata M; Inaba N; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):37-42. PubMed ID: 6174649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of gynecologic tumor markers.
    Bast RC; Hunter V; Knapp RC
    Cancer; 1987 Oct; 60(8 Suppl):1984-92. PubMed ID: 2443235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour antigens associated with primary mediastinal choriocarcinoma.
    Forest JC; Talbot J; Pagé M; Loiselle JM
    Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental alkaline phosphatase, alphafetoprotein and carcinoembryonic antigen in testicular tumors. Tissue typing by means of cytologic smears.
    Wahren B; Holmgren PA; Stigbrand T
    Int J Cancer; 1979 Dec; 24(6):749-53. PubMed ID: 94592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
    Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
    Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.